A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status:
Completed
Trial end date:
2018-02-27
Target enrollment:
Participant gender:
Summary
This study assessed analgesic efficacy of ASP0819 relative to placebo as well as the safety
and tolerability.
This study assessed treatment differences in physical function as well as the improvements in
overall subject status (e.g., fibromyalgia symptoms and global functioning) of ASP0819
relative to placebo.